Mindtech Demonstrates Solutions for AI Training at CES 2020
17.12.2019 11:01:00 EET | Business Wire | Press release
Mindtech Global Ltd, a UK-based start-up, will be at the CTA® Consumer Electronics Show (CES®) in Las Vegas from Jan 5-9th, exhibiting in Eureka Park®, booth 51109, showing their Chameleon product for training neural networks.
Mindtech at CES
Mindtech will be showing demonstrations of our Chameleon product, designed for creating the annotated visual data needed to successfully train and deploy neural networks to solve real-world problems.
Vast quantities of labelled video are required to train neural networks for visual applications; to manually capture and annotate this data has many limitations, including the time and expense involved. To date this has meant only a privileged few can develop and deploy their AI-based computer visions solutions or are perhaps limited to the usage of a few, limited public datasets.
Mindtech changes that with Chameleon, the world’s first tool for synthetic data generation, including a complete virtual world simulator with scenario editor, targeted at all industries that wish to deploy their next-generation, AI-based vision algorithms. The tool allows users to be confident that corner cases which are difficult or impossible to film in the real world have been tested, include sufficient diversity training, and are fully compliant with GDPR. This enhanced data for training helps to prevent embarrassing (or catastrophic) failures in the field.
Whether you are doing drone detection, self-driving cars, smart security cameras or other applications requiring visual stimuli, the Chameleon simulator will provide you with the additional training data you need.
Come and see us at CES, booth 51109 in Eureka Park, and see how we have democratized the acquisition of annotated data.
Contact
For further information or to book a meeting, please contact chris.longstaff@mindtech.global or https://mindtech.global.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20191217005283/en/
Contact information
Neal Leavitt
neal@leavcom.com
760-639-2900
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Avis First Expands to London Heathrow and Paris Charles de Gaulle Airports27.10.2026 14:01:00 EET | Press release
Avis announced the expansion of Avis First to London Heathrow and Paris Charles de Gaulle airports, bringing its premium car rental service to more than 30 airport and city locations across North America and Europe. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261027269041/en/ Avis announced the expansion of Avis First to London Heathrow and Paris Charles de Gaulle airports, bringing its premium car rental service to more than 30 airport and city locations across North America and Europe. Available exclusively through the Avis mobile app, Avis First makes traveling easier and more efficient from the beginning to the end of every trip with coordinated vehicle delivery and return and concierge support throughout the rental. The frictionless experience has resonated with customers as evidenced by high repeat booking rates and strong customer satisfaction ratings. “First class shouldn’t end at the gate,” said Brian Choi, Chief
Pythia Labs Launches with AI-Designed Antibodies for Hard-to-Drug Targets27.10.2026 14:00:00 EET | Press release
Pythia Labs, a biotechnology company building frontier AI models for therapeutic discovery, today announced its launch alongside a preprint in bioRxiv introducing Pythia-1, the all-atom generative model at the core of its antibody design platform. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261027891477/en/ Pythia's AI technology platform can design antibodies against traditionally challenging targets such as multi-pass membrane proteins. Pythia’s technology is built to create antibodies against targets that have challenged conventional discovery, including multi-pass membrane proteins such as G protein-coupled receptors (GPCRs). Generating antibodies that activate these receptors has been a longstanding goal in antibody discovery. Pythia-1 reasons jointly over amino acid sequence, three-dimensional atomic structure and explicit design specifications. The platform provides control over where an antibody binds, the conform
Robbyant’s Inaugural Embodied AI Challenge Draws Over 1,800 Teams Ahead of Real-Robot Final in Shanghai27.10.2026 13:00:00 EET | Press release
Qualifier submissions for the inaugural Robbyant Embodied AI Challenge officially closed on October 27, marking the end of the competition’s online preliminary round. Organized by Robbyant, an embodied AI company within Ant Group, the challenge was launched in September at the 2026 Inclusion Conference on the Bund in partnership with ModelScope and Alibaba Cloud Tianchi. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261027768483/en/ The competition is based on the open-source LingBot-VLA 2.0 embodied foundation model and is designed for developers working on embodied AI algorithms. Participants are evaluated on model training and fine-tuning, simulation-based generalization, and adaptation to real robots. The challenge is open to enterprises, universities, individual developers and technology enthusiasts worldwide. More than 1,800 teams and thousands of developers from 13 countries have registered for the challenge. Partici
Compass Pathways to Announce Third Quarter 2026 Financial Results on November 3, 202627.10.2026 12:30:00 EET | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that it will release financial results for the third quarter ended September 30, 2026, and provide an update on recent developments, on November 3, 2026. Compass management will host a conference call at 8:00 am ET (1:00 pm UK) on November 3, 2026. A live webcast of the call will be available at the following link: https://lifescievents.com/event/csy40je/. The webcast will be archived for 30 days. About Compass Pathways We believe mental health patients deserve the possibility of a better future. Compass Pathways plc (Nasdaq: CMPS) is a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care. Our initial focus is developing COMP360 psilocybin, a proprietary, investigational, synthetic psilocybin treatment under evaluation for treatment-resistant depression (TRD) and post-traumati
Fortegra Appoints Guy House as SVP, Treaty Reinsurance27.10.2026 11:00:00 EET | Press release
The Fortegra Group, Inc. ("Fortegra" or the "Company"), a global specialty insurer and part of DB Insurance Co., Ltd., has appointed Guy House as Senior Vice President, Treaty Reinsurance. In this role, he will lead Fortegra’s treaty reinsurance underwriting strategy from the Company’s UK office. Mr. House brings more than 18 years of London market experience. He has written and bought reinsurance across multiple product lines and tiers, including property, marine, energy, terrorism and aviation. His expertise spans treaty and retrocession reinsurance, direct and facultative (D&F) insurance, exposure management, alongside capital raising and management. Previously, Mr. House was Head of Property at Tamesis Dual, having joined from Markel International where he worked as the Senior Property D&F Underwriter. He is ACII qualified and holds a degree in Economics from Durham University. About Fortegra For more than 45 years, Fortegra, via its subsidiaries, has underwritten risk management s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom